Publication

Publication:

1. Chiu TT, Tsai TL, Su MY, Yang T, Tseng PL, Lee YJ, Lee CH. The Related Risk Factors of Diabetic Retinopathy in Elderly Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort Study in Taiwan. Int J Environ Res Public Health. 2021;18:307.

2. Hsu HC, Chen SY, Lee YJ, Chen WY, Wang RH. Pathways of diabetes distress, decisional balance, self-efficacy and resilience to quality of life in insulin-treated patients with type 2 diabetes: A 9-month prospective study. J Clin Nurs. 2021 Jan 12. doi: 10.1111/jocn.15652. Online ahead of print.

3. Wang RH, Hsu HC, Chen SY, Lee CM, Lee YJ, Ma SM, Chen WY. Risk factors of falls and the gender differences in older adults with diabetes at outpatient clinics. J Adv Nurs. 2021 Feb 21. doi: 10.1111/jan.14795. Online ahead of print.

4. Lu YC, Wu CC, Tsai IT, Hung WC, Lee TL, Hsuan CF, Yu TH, Wei CT, Chung FM, Lee YJ, Wang CP. Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients. Clin Chim Acta. 2021; 516:83-91.

5. Tsai IT, Hung WC, Lu YC, Wu CC, Lee TL, Hsuan CF, Yu TH, Wei CT, Chung FM, Lee YJ, Wang CP. Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function. Int J Med Sci. 2021;18:1-7.

6. Hu J, Hsu H, Yuan X, Lou K, Hsue C, Miller JD, Lu J, Lee Y, Lou Q. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes. J Endocrinol Invest. 2020 Sep 8. doi: 10.1007/s40618-020-01410-6. Epub ahead of print. PMID: 32897535.

7. Tsai IT, Wu CC, Hung WC, Lee TL, Hsuan CF, Wei CT, Lu YC, Yu TH, Chung FM, Lee YJ, Wang CP. FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci. 2020;17:2338-2345.

8. Chao-Ping Wang, Yung-Chuan Lu, Wei-Chin Hung, I-Ting Tsai, Yu-Hung Chang, Der-Wei Hu, Chia-Chang Hsu, Cheng-Ching Wu, Ching-Ting We, Fu-Mei Chung, Yau-Jiunn Lee*. The inter-relationship of risk factors and pathway associated with chronic kidney disease in patients with type 2 diabetes mellitus by using the structural equation models analysis. Public Health. 2021;190:135-144.

9. Chang CJ, Hsu HC, Lee YJ, Wang RH. Associations of Personality, Distress, Social Support With Self-Care Behaviors in Patients With Type 2 Diabetes. Hu Li Za Zhi. 2020;67:40-50.

10. Chang CJ, Hsu HC, Lee YJ, Wang RH. [Associations of Personality, Distress, Social Support With Self-Care Behaviors in Patients With Type 2 Diabetes]. Hu Li Za Zhi. 2020 Dec;67(6):40-50. Chinese. doi: 10.6224/JN.202012_67(6).07. PMID: 33274425.

11. Chi-Chang Chang, Chao-Ping Wang, Wei-Chin Hung, Ching-Ting Wei, Wei-Hua Tang, Cheng-Ching Wu, I-Ting Tsai, Ya-Ai Cheng, Yau-Jiunn Lee, Chia-Chang Hsu. Circulating p-Cresylsulphate Level is Associated with Hepatocellular Carcinoma in Chronic Hepatitis B or C Virus Infection. E-Da Medical Journal. 2020;7:11-21

12. Lee YJ, Wang CP, Hung WC, Tang WH, Chang YH, Hu DW, Lu YC, Yu TH, Wu CC, Chung FM, Hsu CC. Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients. Diabetes Metab Syndr Obes. 2020;13:1203-1214.

13. Lu YC, Chang CC, Wang CP, Hung WC, Tsai IT, Tang WH, Wu CC, Wei CT, Chung FM, Lee YJ, Hsu CC. Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Int J Med Sci. 2020 Jan 14;17:182-190.

14. Chang YH, Lin HC, Hwu DW, Chang DM, Lin KC, Lee YJ. Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Ann Clin Biochem. 2019 Jan;56(1):141-147. doi: 10.1177/0004563218796259. Epub 2018 Aug 27. PMID: 30089409.

15. Wu CC, Chang CS, Hsu CC, Wang CP, Tsai IT, Lu YC, Houng JY, Chang CC, Chung FM, Lee YJ, Hung WC. Elevated Plasma Adiponectin Levels are Associated with Abnormal Corrected QT Interval in Patients with Stable Angina. Int Heart J. 2020 Jan 31;61:29-38.

16. Hsu HC, Lee YJ, Wang RH. [Decision Cycle for Patient-Centered Glycemic Management in Type 2 Diabetes]. Hu Li Za Zhi. 2019 Dec;66(6):5-12. Chinese. doi:10.6224/JN.201912_66(6).02. PMID: 31802449.

17. Hsu HC, Chen SY, Huang YC, Wang RH, Lee YJ, An LW. Decisional Balance for Insulin Injection: Scale Development and Psychometric Testing. J Nurs Res. 2019;27:e42.

18. Wang CP, Hsu CC, Hung WC, Yu TH, Wu CC, Tsai IT, Tang WH, Chung FM, Houng JY, Lee YJ, Lu YC. Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease. BMC Cardiovasc Disord. 2019; 19:153.

19. Chen SY, Hsu HC, Wang RH, Lee YJ, Hsieh CH. Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes: Empowerment Perceptions and Diabetes Distress as Important Determinants. Biol Res Nurs. 2019;21:182-189.

20. Wang RH, Hsu HC, Chen SY, Hsieh CH, Lee YJ*. Modeling patient empowerment and health literacy to glycemic control in insulin-treated patients: A prospective study. Patient Educ Couns. 2019;102:1336-1341.

21. YH, Lin HC, Hwu DW, Chang DM, Lin KC, Lee YJ*. Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Ann Clin Biochem. 2019;56:141-147.

22. Wang RH, Lin KC, Hsu HC, Lee YJ, Shin SJ. Determinants for quality of life trajectory patterns in patients with type 2 diabetes. Qual Life Res. 2019;28:481-490.

23. Mei-Chu Yen Jean, Chia-Chang Hsu, Wei-Chin Hung, Yung-Chuan Lu, Chao-Ping Wang, I-Ting Tsai, I-Cheng Lu, Yi-Hsin Hung, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu. Association between lifestyle and hematological parameters: a study of Chinese male steel workers. J Clin Lab Anal. 2019;33:e22946.

24. Li-Wen Lin, Teng-Hung Yu, Wei-Chin Hung, Chao-Ping Wang, Cheng-Ching Wu, I-Ting Tsai, Chia-Chang Hsu, Ya-Ai Cheng, Yau-Jiunn Lee, Yung-Chuan Lu. Periodontal Disease is Associated with Metabolic Syndrome-The Role of Peripheral Total and Differential Leukocyte Count-Related Metabolic Derangements. E-Da Medical Journal. 2018;5:1-30

25. Wu CC, Lu YC, Yu TH, Wang CP, Hung WC, Tang WH, Tsai IT, Chung FM, Lee YJ, Hu JJ. Serum albumin level and abnormal QTc interval in patients with coronary artery disease and chronic kidney disease. Intern Med J. 2018;48:1242-1251.

26. Yu TH, Tang WH, Lu YC, Wang CP, Hung WC, Wu CC, Tsai IT, Chung FM, Houng JY, Lan WC, Lee YJ*. Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients. Clin Chim Acta. 2018;484:47-51.

27. Wang CP, Yu TH, Wu CC, Hung WC, Hsu CC, Tsai IT, Tang WH, Chung FM, Houng JY, Lee YJ, Lu YC. Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction. Cytokine. 2018; 110:367-373.

28. Tang WH, Wang CP, Yu TH, Tai PY, Liang SS, Hung WC, Wu CC, Huang SH, Lee YJ, Chen SC. Protein-bounded uremic toxin p-cresylsulfate induces vascular permeability alternations. Histochemistry and Cell Biology. 2018;149:607-617.

29. Hsu HC, Lee YJ, Wang RH. Influencing Pathways to Quality of Life and HbA1c in Patients With Diabetes: A Longitudinal Study That Inform Evidence-Based Practice. Worldviews Evid Based Nurs. 2018;15:104-112.

30. Hwu DW, Lin KD, Lin KC, Lee YJ, Chang YH. The association of obstructive sleep apnea and renal outcomes-a systematic review and meta-analysis. BMC Nephrol. 2017;18:313.

31. Chang YH, Hwu DW, Chang DM, An LW, Hsieh CH, Lee YJ*. Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus. Acta Diabetol. 2017;54:561-568.

32. Chang YH, Hwu DW, Chang DM, An LW, Hsieh CH, Lee YJ*. Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus. Acta Diabetol. 2017;54:561-568.

33. Wang RH, Hsu HC, Kao CC, Yang YM, Lee YJ, Shin SJ. Associations of changes in psychosocial factors and their interactions with diabetes distress in patients with type 2 diabetes: a longitudinal study. J Adv Nurs. 2017;73:1137-1146.

34. Tsai IT, Wang CP, Yu TH, Lu YC, Lin CW, Lu LF, Wu CC, Chung FM, Lee YJ, Hung WC, Hsu CC. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection. Cytokine. 2017;90:54-59.

35. Tsai IT, Wang CP, Lu YC, Hung WC, Wu CC, Lu LF, Chung FM, Hsu CC, Lee YJ, Yu TH. The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovasc Disord. 2017;17:1.

36. Chang YH, Hwu DW, Kao WP, Lee YJ*. Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3. Rev Diabet Stud. 2016 Winter;13(4):212-214.

37. Wang RH, Hsu HC, Lee YJ, Shin SJ, Lin KD, An LW. Patient empowerment interacts with health literacy to associate with subsequent self-management behaviors in patients with type 2 diabetes: A prospective study in Taiwan. 2016;99:1626-31.

38. Lee YJ, Wang MY, Lin MC, Lin PT. Associations between Vitamin B-12 Status and Oxidative Stress and Inflammation in Diabetic Vegetarians and Omnivores. Nutrients. 2016;8(3). pii: E118.

39. Lee YJ, Shin SJ, Wang RH, Lin KD, Lee YL, Wang YH. Pathways of empowerment perceptions, health literacy, self-efficacy, and self-care behaviors to glycemic control in patients with type 2 diabetes mellitus. Patient Educ Couns. 2016;99:287-94.

40. Li-Fen Lu, Chao-Ping Wang, Teng-Hung Yu, Wei-Chin Hung, Yau-Jiunn Lee, Yung-Chuan Lu. Factors Associated with New Onset of Microalbuminuria in Patients with Type 2 Diabetes. E-Da Medical Journal. 2016;3:1-10.

41. Wang CP, Lu YC, Tsai IT, Tang WH, Hsu CC, Hung WC, Yu TH, Chen SC, Chung FM, Lee YJ, Houng JY. Increased Levels of Total p-Cresylsulphate are Associated with Pruritus in Patients with Chronic Kidney Disease. Dermatology. 2016, 232:363-70.

42. Lu LF, Tang WH, Hsu CC, Tsai IT, Hung WC, Yu TH, Wu CC, Chung FM, Lu YC, Lee YJ, Wang CP. Associations among chronic kidney disease, high total p-cresylsulfate and left ventricular systolic dysfunction. Clin Chim Acta. 2016;457:63-68.

43. Chang YH, Lei CC, Lin KC, Chang DM, Hsieh CH, Lee YJ*. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study. Diabetes Metab Res Rev. 2016;32:557-64.

44. Wu CC, Lin HY, Wang CP, Lu LF, Yu TH, Hung WC, Houng JY, Chung FM, Lee YJ, Hu JJ. Evaluation of a rapid quantitative determination method of PSA concentration with gold immunochromatographic strips. BMC Urol. 2015;15:109.

45. Hung WC, Yu TH, Hsu CC, Lu LF, Chung FM, Tsai IT, Lu YC, Houng JY, Lee YJ, Wang CP. Plasma visfatin levels are associated with major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction. Clin Invest Med. 2015;38:E100-9.

46. Hung WC, Tang WH, Wang CP, Lu LF, Chung FM, Lu YC, Hsu CC, Tsai IT, Jhuo SJ, Lai WT, Lee YJ, Yu TH. Increased epicardial adipose tissue volume is associated with PR interval prolongation. Clin Invest Med. 2015;38:E45-52.

47. Tang WH, Wang CP, Chung FM, Huang LL, Yu TH, Hung WC, Lu LF, Chen PY, Luo CH, Lee KT, Lee YJ, Lai WT. Uremic Retention Solute Indoxyl Sulfate Level Is Associated with Prolonged QTc Interval in Early CKD Patients. PLoS One. 2015;10:e0119545.

48. Tang WH, Wang CP, Yu TH, Hung WC, Chung FM, Lu YC, Hsu CC, Lu LF, Huang LL, Lee YJ, Lai WT. Serum total p-cresylsulfate level is associated with abnormal QTc interval in stable angina patients with early stage of renal failure. Clin Chim Acta. 2014;437C:25-30.

49. Tang WH, Wang CP, Yu TH, Hung WC, Chung FM, Lu YC, Hsu CC, Lu LF, Huang LL, Lee YJ, Lai WT. Serum total p-cresylsulfate level is associated with abnormal QTc interval in stable angina patients with early stage of renal failure. Clin Chim Acta. 2014;437C:25-30.

50. Li-Wen Lin, Yung-Chuan Lu, Chao-Ping Wang, Chia-Chang Hsu, Li-Fen Lu, Ming-Che Hsin, I-Ting Tsai, Fu-Mei Chung, Jer-Yiing Houng, Yau-Jiunn Lee, Chih-Yu Chena. Visfatin/pre-B cell colony-enhancing factor immunohistochemical overexpression in oral cancers. Journal of Applied Biomedicine. 2014;12:255-62.

51. Chang YH, Lin KD, Shin SJ, Lee YJ*. Changes in high-density-lipoprotein cholesterol upon statin treatment in type 2 diabetic patients: A meta-analysis. Nutr Metab Cardiovasc Dis. 2014;24:1067-73.

52. YH, Lin KC, Chang DM, Hsieh CH, Lee YJ*. Paradoxical negative HDL cholesterol response to atorvastatin and simvastatin treatment in Chinese type 2 diabetic patients. Rev Diabet Stud. 2013;10:213-22.

53. Chang YH, Hsieh MC, Wang CY, Lin KC, Lee YJ*. Reassessing the benefits of statins in the prevention of cardiovascular disease in diabetic patients--a systematic review and meta-analysis. Rev Diabet Stud. 2013;10:157-70.

54. Lu YC, Hsu CC, Yu TH, Wang CP, Lu LF, Hung WC, Chiu CA, Chung FM, Lee YJ, Tsai IT. Association between visfatin levels and coronary artery disease in patients with chronic kidney disease. Iran J Kidney Dis. 2013;7:446-52.

55. Tsai YD, Wang CP, Chen CY, Lin LW, Hwang TZ, Lu LF, Hsu HF, Chung FM, Lee YJ, Houng JY. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck. 2014 Jul;36:947-53.

56. Lu YC, Wang CP, Hsu CC, Chiu CA, Yu TH, Hung WC, Lu LF, Chung FM, Tsai IT, Lin HC, Lee YJ*. Circulating secreted frizzled-related protein 5 and wingless-type MMTV integration site family member 5a levels in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2013;29:551-6.

57. Hsu CC, Lu YC , Chiu CA, Yu TH, Hung WC, Wang CP, Lu LF, Chung FM, Lee YJ, Tsai IT. High levels of indoxyl sulfate are associated with severity of coronary atherosclerosis. Clin Invest Med. 2013; 36: E42.

58. Chiu CA, Yu TH, Hung WC, Lu LF, Chung FM, Tsai IT, Yang CY, Hsu CC, Lu TC, Houng JY, Lee YJ, Wang CP. Increased expression of visfatin in monocytes and macrophages in male acute myocardial infarction patients. Mediators of Inflammation. 2012; 2012: 469852.

59. Tsai YD, Wang CP, Chen CY, Lin LW, Lin TM, Hsu CC, Chung FM, Lin HC, Hsu HF, Lee YJ, Houng JY. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in male oral squamous cell carcinoma patients. Med Oral Patol Oral Cir Bucal. 2013; 18: e180-6.

60. Chang YH, Chang DM, Lin KC, Hsieh CH, Lee YJ*. High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2013; 23:751-7.

61. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ*. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev. 2011;27:515-27.

62. Lu LF, Wang CP, Yu TH, Hung WC, Chiu CA, Chung FM, Tsai IT, Yang CY, Cheng YA, Lee YJ, Yeh LR. Interpretation of elevated plasma visfatin concentrations in patients with ST-elevation myocardial infarction. Cytokine. 2012;57:74-80.

63. Wang CP, Lu LF, Yu TH, Hung WC, Chiu CA, Chung FM, Hsu CC, Lu YC, Lee YJ, Houng JY. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events. J Nephrol. 2013;26:111-8.

64. Chiu CA, Lu LF, Yu TH, Hung WC, Chung FM, Tsai IT, Yang CY, Hsu CC, Lu YC, Wang CP, Lee YJ*. Increased levels of total p-cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy. Rev Diabet Stud 2010; 7: 275-284.

65. Hung WC, Wang CP, Lu LF, Yu TH, Chiu CA, Chung FM, Chen HJ, Houng JY, Shin SJ, Lee YJ*. Circulating adiponectin level is associated with major adverse cardiovascular events in Type 2 diabetic patients with coronary artery disease. Endocr J 2010;57:793-802.

66. Wang CP, Lu LF, Yu TH, Hung WC, Chiu CA, Chung FM, Yeh LR, Chen HJ, Lee YJ, Houng JY. Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure. Atherosclerosis. 2010; 211: 579-83.

67. C-P Wang, W-C Hung, T-H Yu, C-A Chiu, L-F Lu , F-M Chung, C-H Hung, S-J Shin, H-J Chen, Y-J Lee*. Genetic Variation in the G-50T Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 Gene and the Risk of Younger Onset Type 2 Diabetes among Chinese Population: Potential Interaction with Body Mass Index and Family History. Exp Clin Endocrinol Diabetes 2009; 117: 1-7.

68. Lu LF, Yang SS, Wang CP, Hung WC, Yu TH, Chiu CA, Chung FM, Shin SJ, Lee YJ*. Elevated Visfatin/Pre-B-cell Colony-enhancing Factor Plasma Concentration in Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. Journal of Stroke and Cerebrovascular Diseases. 2009 ; 18: 354-9.

69. Chao-Ping Wang, Hui-Ling Hsu, Wei-Chin Hung, Teng-Hung Yu, Yen-Hsun Chen, Cheng-An Chiu, Li-Fen Lu, Fu-Mei Chung, Shyi-Jang Shin, Yau-Jiunn Lee*. Increased epicardial adipose tissue volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clinical Endocrinology. 2009 Jun;70:876-82.

70. Wang CP, Hung WC, Yu TH, Hsu HL, Chen YH, Chiu CA, Lu LF, Chung FM, Cheng YA, Lee YJ*. Brachial- ankle pulse wave velocity as an early indicator of left ventricular diastolic function among hypertensive subjects. Clinical and Experimental Hypertension. 2009; 31:31-43.

71. Wang CP, Chung FM, Shin SJ, Lee YJ*. Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance. Rev Diabet Stud 2007; 77-84.

72. Chung F-M, Shieh T-Y, Yang Y-H, Chang D-M, Shin S-J, Tsai J C-R, Chen T H-H, Tai T-Y, Lee Y-J*. The role of angiotensin-converting enzyme gene insertion/deletion polymorphism for blood pressure regulation in areca nut chewers. Translational Research 2007; 150: 58-65.

73. Chen M-P, Chung F-M, Chang D-M, Tsai J C-R, Huang H-F, Shin S-J, Lee Y-J*. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev Diabetic Stud 2006;3:21-30.

74. Chung F-M, Chang D-M, Chen M-P, Tsai JCR, Yang Y-H, Shieh T0Y, Shin S-J, Chen THH, Tai T-Y, Lee Y-J*. Areca Nut Chewing is Associated with Metabolic Syndrome-Role of Tumor Necrosis Factor-alpha, Leptin, and WBC Count in Betel Nut Chewing-Related Metabolic Derangements. Diabetes Care 2006;29:1714.

75. Tsai J C-R, Sheu S-H, Chiu H-C, Chung F-M, Chang D-M, Chen M-P, Shin S-J, Lee Y-J*. Association of peripheral total and differential leukocytes counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus. Diab Metab Res Rev 2007;23:111-118.

76. Chen M-P, Chung F-M, Chang D-M, Tsai J C-R, Huang H-F, Shin S-J, Lee Y-J*. Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 2006;91:295-299.

77. Lee YJ. The role of gender in estimating glomerular filtration rate. (Letter and reply) Nephrol Dial Transplant. 2006;21:819-820.

78. Chung F-M, Tsai J C-R, Chang , Shin S-J, Lee Y-J *. Peripheral total and differential leukocyte count in diabetic nephropathy: The relationship of plasma leptin to leukocytosis. Diabetes Care. 2005,28:1710-7.

79. Chung F-M, Yang Y-H, Shieh T-Y, Shin S-J, Tsai J C-R, Lee Y-J *. Effect of alcohol consumption on estimated glomerular filtration rate and creatinine clearance rate. Nephrol Dial Transp 2005, 20:1610-6.

80. Chen MP, Tsai JC, Chung FM, Yang SS, Hsing LL, Shin SJ, Lee YJ*. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol. 2005;25:821-6.

81. Chao P-J, Tsai J C-R, Chang D-M, Shin S-J, Lee Y-J *. A Case of Acquired Generalized Lipodystrophy with Cerebellar Degeneration and Type 2 Diabetes Mellitus. Rev Diab Stud 2004;1:193-197.

82. Tsai J C-R, Chang D-M, Chung F-M, Wu J-C, Shin S-J, Lee Y-J *. The Association of Silent Coronary Artery Disease and Metabolic Syndrome in Chinese with Type 2 Diabetes Mellitus. Rev Diab Stud 2004;1:18-28.

83. Tan M-S, Chang S-Y, Chang D-M, Tsai J-C, Lee Y-J*. Association of resistin gene 3’UTR +62GA polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocrinol Metab 2003;88: 1258-63.

84. Lee Y-J*, Tsai J C-R. Response to costa (letter). Diabetes Care 2002;25:2366-7.

85. Lee Y-J*, Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002;25:1002-8

86. Lee Y-J*, Tsai JCR. Angiotensin Converting Enzyme Gene Insertion/Deletion, not Bradykinin B2 Receptor -58T/C Gene Polymorphism, Associated with Angiotensin-Converting Enzyme Inhibitor-Related Cough in Chinese Female Patients with NIDDM. Metabolism 2001;50:1346-50.

87. Hsieh T-J, Lin S-R, Lee Y-J, Shin S-J, Lai Y-H, Hsu C-H, Tsai J-H. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats. Am J Physiol Renal Physiol 2000; 279:F112-21.

88. Lee Y-J*, Chiang Y-F, Tsai J C-R. Severe nonproductive cough and cough-induced urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor. Diabetes Care 2000;23:427-428.

89. Lai F-J, Shin S-J, Lee Y-J, Lin S-R, Jou W-Y, Tsai J-H. Up-regulation of adrenal cortical and medullary atrial natriuretic peptide and gene expression in rats with deoxycorticosterone acetate-salt treatment. Endocrinology 2000;141:325-332.

90. Shin S-J, Hsiao P-J, Hsieh M-C, Lee Y-J, Tsai J-H. Increased urinary endothelin-1 excretion in newly diagnosed type 2 diabetic patients. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1999;15:589-596.

91. Shin S-J, Lee Y-J, Hsiao P-J, Tsai J-H. Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome. Diabetes Care 1999 ;22:1181-1185.

92. Hwang Y-S, Hsieh T-J, Lee Y-J, Tsai J-H. Circadian Rhythm of Urinary Endothelin-1 Excretion in Mild Hypertensive Patients. Am J Hypertens1998;11:1344-51.

93. Shin S-J, Wen J-D, Lee Y-J, Chen I-H, Tsai J-H. Increased C-type natriuretic peptide mRNA expression in the kidney of diabetic rats. J Endocrinol 1998;158:35-42.

94. Shin S-J, Lee Y-J, Tan M-S, Hsieh T-J, Tsai J-H. Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats. Kidney Int 1997;51:1100-1105.

95. Tan M-S, Lee Y-J, Shin S-J, Tsai J-H. Oxidized low-density lipoprotein stimulates endothelin-1 release and mRNA expression from rat mesangial cells. J Lab Clin Med 1997;129:224-230.

96. Shin S-J, Lee Y-J, Hsiao P-J, Chen J-H, Guh J-Y, Chen M-T, Chen W-C, Tsai J-H. Relationship between *-cell function and diabetic duration and albuminuria in type 2 diabetes mellitus. Pancreas 1997;14:192-198.

97. Lee Y-J, Shin S-J, Tan M-S, Hsieh T-J, Tsai J-H. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment. Am J Physiol 1996;271:F779-F789.

98. Shin S-J, Lee Y-J, Tsai J-H. The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes. Scand J Clin Lab Invest 1996;56:571-576.

99. Wei S-Y, Shin S-J, Chen J-H, Chang J-M, Sung M-H, Lee Y-M, Wang S-L, Tsai J-J, Lee Y-J, Lai Y-H. Major causes of diabetic death at one hospital. Kaohsiung J Med Sci 1996;12:216-220.

100. Chang C-J, Shin S-J, Lee W-L, Lee Y-J, Horng N-C, Liu H-W. Hypercholesterolemia in undiagnosed non-insulin-dependent diabetes in southern Taiwan. Kaohsiung J Med Sci 1996;12:221-228.

101. Lee Y-J. Application of molecular biology in clinical endocrinology. J Intern Med ROC 1996;7:261-264.

102. Lee Y-J, Shin S-J, Lin S-R, Tan M-S, Tsai J-H. Increased expression of heparin binding-epidermal growth factor like growth factor mRNA in the kidney of streptozotocin induced diabetic rats. Biochem Biophys Res Commun 1995;207:216-222.

103. Shin S-J, Lee Y-J, Lin S-R, Tan M-S, Lai Y-H, Tsai J-H. Decreased of renal endothelin-1 content and gene expression in diabetic rats with moderate hyperglycemia. Nephron 1995;70:486-493.

104. Lee Y-J, Lin S-R, Shin S-J, Lai Y-H, Tsai J-H. Brain natriuretic peptide is synthesized in the human adrenal medulla and its mRNA expression, along with atrial natriuretic peptide, is enhanced in patients with primary aldosteronism. J Clin Endocrinol Metab 1994;79:1476-1482.

105. Tan M-S, Lee Y-J, Shin S-J, Tsai J-H. Regulation of heparin binding-epidermal growth factor like growth factor gene expression by LDL and oxidized-LDL in rat mesangial cells. Biochem Biophys Res Commun 1994;202:1001-1008.

106. Tan M-S, Tsai J-C, Lee Y-J, Chen H-C, Shin S-J, Lai Y-H, Perrella MA, Bianchi C, Higashiyama S, Endege W, Lee M-E, Tsai J-H. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by protein kinase C activators. Kidney Int 1994;46:690-695.

107. Lee Y-J, Shin S-J, Tsai J-H. Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 1994;17:263-266.

108. Lin S-R, Lee Y-J, Tsai J-H. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 1994;78:483-491.

109. Lee Y-J, Lin S-R, Shin S-J, Tsai J-H. Increased adrenomedullary ANP synthesis in patients with primary aldosteronism. J Clin Endocrinol Metab 1993;76:1357-1362.

110. Voon W-C, Sheu S-H, Yen H-W, Chang J-S, Lin C-C, Lai W-T, Lee Y-J*. Effect of ionic contrast medium on plasma atrial natriuretic peptide. Kaohsiung J Med Sci 1993;9:518-523.

111. Chang C-J, Shin S-J, Lee W-L, Horng N-C, Lee Y-J, Liu H-W. Influence of central obesity and obesity level on the prevalence of NIDDM and impaired glucose tolerance. Kaohsiung J Med Sci 1992;8:647-655.

112. Yang R-T, Lai Y-H, Shin S-J, Lee Y-J, Tsai JH. Renal size in various stages of NIDDM nephropathy. J Nephrology ROC 1991;5:11-18.

113. Lee Y-J, Wu C-C, Yang S-S, Yang K T-A, Chuang H-C, Hsu B-S, Shin S-J, Torng J-K, Chang W-Y, Tsai J-H. Thyroid function in normal Chinese. Ann Nucl Med 1990;3:61-66.

114. Shin S-J, Lee Y-J, Hsiao P-J, Lin L, Wang S-F, Chang F-T, Chuang F-J, Tsai J-H. The variability of 24-hour, overnight 12-hour, and morning one-hour, urinary albumin excretion in normoalbuminuric and microalbuminuric hospitalized diabetics. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 1990 Sep;6(9):511-516.

115. Chien C-H, Tsai J-H, Lee Y-J. Atrial natriuretic polypeptide in human adrenal pheochromocytoma: immunohistochemical and immunoelectron microscopical localization. Endocrinol Jpn 1990 Feb;37(1):121-130.

116. Lee Y-J, Tsai J-H, Lai Y-H, Torng J-K, Shin S-J, Wu C-C. Anterior pituitary functions in patients with uremia tested by stimulation with four combined hypothalamic releasing hormones. Taiwan I Hsueh Hui Tsa Chih 1989 Nov;88(11-12):1091-1096.

117. Lee Y-J, Tsai J-H, Shin S-J, Torng J-K, Lai Y-H, Guh J-Y, Chen J-H. Hypogonadotropinemia in non-thyroidal, non-pituitary critically ill post-menopausal women. Taiwan I Hsueh Hui Tsa Chih 1988 Aug;87(8):765-772.

118. Shin S-J, Tsai J-H, Lee Y-J, Lai Y-H, Torng J-K, Chen J-H, Her S-S. Confirmation of thyrotropin decrease in nonthyroidal illness by sensitive immunoradiometric assay for thyrotropin. Taiwan I Hsueh Hui Tsa Chih 1987 Aug;86(8):811-817.

119. Lee Y-J, Shin S-J, Torng J-K, Liu W-J, Tsai J-H. Insulin autoimmune syndrome in a methimazole-treated Graves' patient with polyclonal anti-insulin autoantibodies: report of a case. Taiwan I Hsueh Hui Tsa Chih 1987 Feb;86(2):164-170.

120. Yang K-T, Lee Y-J, Wu C-C. Receiver operating characteristic analysis of isotopes scanning in detection of diffuse goiter. Taiwan I Hsueh Hui Tsa Chih 1986 Dec;85(12):1183-1188.

121. Lee Y-J, Tsai J-H, Shin S-J, Torng J-K, Lai Y-H, Pan J-S, Her S-S, Wu C-C. Sensitive immunoradiometric assay for thyrotropin to distinguish primary hyperthyroidism and secondary hypothyroidism from normals. Taiwan I Hsueh Hui Tsa Chih 1986 Dec;85(12):1169-1176.

122. Yang K-T, Lee Y-J, Wu C-C. Measurements of the thyroid scans of normal persons and diffuse toxic goiter in Taiwan. Taiwan I Hsueh Hui Tsa Chih 1986 May;85(5):479-482.